Bone Grafts and Substitutes Market by Type (Bone Graft Substitutes, Allograft, Cell-based Matrices), Material Type (Collagen, Human Cell Source, Animal Source, Hydroxyapatite, Tricalcium Phosphate, Others), Application (Spinal Fusion, Trauma, Dental Bone Grafting, Craniomaxillofacial, Joint Reconstruction) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Bone Grafts and Substitutes Market

Industry:  Life Sciences & Healthcare | Publish Date: Jun 2020 | No of Pages:  400 | No. Tables:  197 | No. Figures:  173

Market Definition

The global Bone Grafts and Substitutes Market size valued USD 2.96 billion in 2019, and is predicted to reach USD 4.85 billion by 2030, witnessing a CAGR of 4.5% from 2020-2030. Bone grafting is a surgical procedure to operate extremely complicated bone fractures whereas bone grafts are implantable materials, used during the procedure to promote bone healing, bone formation, and osseous reconstruction.

Depending on the grafting procedure, the bone grafts may be autologous, allograft or synthetic with mechanical properties replicating the bone. These grafts soon get reabsorbed and replaced with the healing of natural bone, and their efficacy depend on three basic principles viz. osteoconduction, osteoinduction, and osteogenesis. Bone grafts hold wide applications in spinal fusion, trauma, dental bone grafting, craniomaxillofacial, joint reconstruction and other bone grafting procedures.

Market Dynamics and Trends

According to World Population Ageing data provided by the United Nations, the global population aged 60 years or above numbered 962 million in 2017, and is expected to reach 2.1 billion by 2050. According to the report published by Centres for Disease Control and Prevention, in 2017, 60% of the elderly population was affected by spinal deformities. This prevailing condition gives rise to an increase in demand for bone grafts and substitutes in the grafting procedures, hence propagating the growth of the bone grafts and substitutes market.

The global bone grafts and substitutes market has observed substantial growth in the past few years, and is expected to witness gigantic opportunities, in the coming future. The factors fostering the market growth are, increasing rate of spinal deformities, multiplying number of road accidents and sports injuries, growing incidences of joint disorders, hip fractures, osteoporosis and arthritis, especially in women. Growing demand for dental bone grafts, higher adoption of minimally invasive surgeries, lucrative benefits offered by health-care insurance and Mediclaim agencies.

However, high cost of bone grafting surgeries, as well as risk and complications associated with grafting procedures, are the factors responsible in hampering the bone grafts and substitutes market growth during the forecast period. Moreover, factors such as increase in per-capita disposable income, advancements in healthcare infrastructures, growing penetration of orthopedic specialty hospitals, increasing government initiatives offering low-cost medical services and subsidiaries, as well as upsurge in R&D activities regarding biocompatible synthetic bone grafts, are anticipated in providing avenues for the growth of bone grafts and substitutes market in the coming future.

 

Market Segmentations and Scope of the Study:

The bone grafts and substitutes market share analysis is based on type, application, material type, and geography. Based on type, the market is segmented into bone graft substitutes, allograft, and cell-based matrices. Based on application, the market covers spinal fusion, trauma, dental bone grafting, craniomaxillofacial, and joint reconstruction.

Based on the type of material, the bone grafts and substitutes market is divided into collagen, hydroxyapatite, tricalcium phosphate, human cell source, animal source, and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

 

Geographical Analysis

North America region is expected to dominate the global bone grafts and substitutes industry throughout the forecast period, accounting for the highest market shares. This is attributed to factors such as well-established orthopedic specialty healthcare infrastructures, better reimbursement facilities, higher adoption of advanced medical technologies, higher investments in R&D activities, and presence of key players in this region.

It is expected that the emerging economies, specifically in the Asia-Pacific region shall witness increasing size of the bone grafts and substitutes market, owing to rapidly increasing geriatric population, growing adoption of bone grafts and substitutes in grafting modalities, as well as presence of large patient pool migrates in this region.

 

Competitive Landscape

Comprehensive competitive analysis and profiles of the major market players such as Johnson & Johnson, Arthrex, Inc., Baxter International Inc., Zimmer Biomet Holdings, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Stryker Corporation, Musculoskeletal Transplant Foundation, NuVasive, Inc., Medtronic Plc., Inc., and others are provided in the bone grafts and substitutes market report.

An upsurge in R&D activities and advancement in product technology with new product launches by the key players, is leading the healthcare infrastructure to new heights, by creating lucrative opportunities for the global bone grafts and substitutes market.

For instance, in January 2020, Medtronic Plc., a global leader in medical technology, chose Barrow Neurological Institute (BNI) at the Phoenix Children’s Hospital, a Nationally ranked pediatric leader in the US, as its first partner for application of its  ‘Medtronic Stealth Autoguide: the Cranial Robotic Guidance Platform for Neurosurgery.’ This robotic technology is FDA approved and its highly advanced surgical tools are intended for use with the Medtronic Stealth Station system. The Phoenix Children’s Hospital aims at using this robotic technology in surgery for pediatric patients suffering from a range of neurological conditions, hence being at the forefront of surgical innovations and having the most advanced solutions for pediatric patients.

KEY BENEFITS

  • The bone grafts and substitutes market report provide a quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.

  • The study comprises a deep dive analysis of the bone grafts and substitutes industry, including current and future market trends for depicting the prevalent investment pockets in the market.

  • The report provides detailed information related to key drivers, restraints, opportunities and their impact on the global market.

  • The report incorporates competitive analysis of the market players along with their market size and share in the global market for bone grafts and substitutes.

  • The study elaborates on the SWOT analysis and Porter's Five Forces model along with bone grafts and substitutes market trend analysis.

  • Value chain analysis in the bone grafts and substitutes market study provides a clear picture of the stakeholders’ roles.

BONE GRAFTS AND SUBSTITUTES MARKET KEY SEGMENTS

By Type

  • Bone Graft Substitutes

  • Allograft

  • Cell-based Matrices

By Application

  • Spinal Fusion

  • Trauma

  • Dental Bone Grafting

  • Craniomaxillofacial

  • Joint Reconstruction

By Material Type

  • Collagen

  • Human Cell Source

  • Animal Source

  • Hydroxyapatite

  • Tricalcium Phosphate

  • Others

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia

    • Rest of Asia-Pacific

  • RoW

    • UAE

    • Saudi Arabia

    • South Africa

    • Brazil

    • Rest of RoW

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2019–2030

Base Year Considered

2019

Forecast Period

2020–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Type (Bone Graft Substitutes, Allograft, Cell-based Matrices), Material Type (Collagen, Human Cell Source, Animal Source, Hydroxyapatite, Tricalcium Phosphate, Others), Application (Spinal Fusion, Trauma, Dental Bone Grafting, Craniomaxillofacial, Joint Reconstruction)

Geographical Segmentation

North America (US, Canada, Mexico) Europe (Germany, UK, France, Italy, Rest of Europe) APAC (China, Japan, India, Australia, Rest of APAC) Rest of World (UAE, Saudi Arabia, South Africa, Brazil, Rest of RoW)

Companies Profiled

Johnson & Johnson, Arthrex, Inc., Baxter International Inc., Zimmer Biomet Holdings, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Stryker Corporation, Musculoskeletal Transplant Foundation, NuVasive, Inc., Medtronic Plc., Inc.

Test

1. INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           RESEARCH METHODOLOGY

1.2.1             SECONDARY RESEARCH

1.2.2             DATA ANALYSIS FRAMEWORK

1.2.3             MARKET SIZE ESTIMATION

1.2.4             FORECASTING

1.2.5             PRIMARY RESEARCH AND DATA VALIDATION

2. MARKET SNAPSHOT, 2022-2030 MILLION USD

2.1.           MARKET SNAPSHOT

3. PORTER’S FIVE FORCE MODEL ANALYSIS

4. MARKET SHARE ANALYSIS

5. MARKET DYNAMICS

5.1.           GROWTH DRIVERS

5.1.1             DRIVER 1

5.1.2             DRIVER 2

5.1.3             DRIVER 3

5.1.4             DRIVER 4

5.2.           CHALLENGES

5.2.1             CHALLENGE 1

5.2.2             CHALLENGE 2

5.3.           OPPORTUNITIES

5.3.1             OPPORTUNITY 1

5.3.2             OPPORTUNITY 2

6. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

6.1.           OVERVIEW

6.2.           ALLOGRAFT

6.2.1             GLOBAL ALLOGRAFT MARKET, BY PRODUCT

6.2.1.1        DEMINERALIZED BONE MATRIX (DBM) MARKET, BY REGION

6.2.1.1.1        NORTH AMERICA DEMINERALIZED BONE MATRIX (DBM) MARKET, BY COUNTRY

6.2.1.1.2        EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET, BY COUNTRY

6.2.1.1.3        ASIA-PACIFIC DEMINERALIZED BONE MATRIX (DBM) MARKET, BY COUNTRY

6.2.1.1.4        REST OF WORLD DEMINERALIZED BONE MATRIX (DBM) MARKET, BY COUNTRY

6.2.1.2        MACHINED ALLOGRAFTS MARKET, BY REGION

6.2.1.2.1        NORTH AMERICA MACHINED ALLOGRAFTS MARKET, BY COUNTRY

6.2.1.2.2        EUROPE MACHINED ALLOGRAFTS MARKET, BY COUNTRY

6.2.1.2.3        ASIA-PACIFIC MACHINED ALLOGRAFTS MARKET, BY COUNTRY

6.2.1.2.4        REST OF WORLD MACHINED ALLOGRAFTS MARKET, BY COUNTRY

6.2.2             ALLOGRAFT MARKET, BY REGION

6.2.2.1        NORTH AMERICA ALLOGRAFT MARKET, BY COUNTRY

6.2.2.2        EUROPE ALLOGRAFT MARKET, BY COUNTRY

6.2.2.3        ASIA-PACIFIC ALLOGRAFT MARKET, BY COUNTRY

6.2.2.4        REST OF WORLD ALLOGRAFT MARKET, BY COUNTRY

6.3.           BONE GRAFT SUBSTITUTES

6.3.1             GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

6.3.1.1        BONE MORPHOGENIC PROTEINS (BMP) MARKET, BY REGION

6.3.1.1.1        NORTH AMERICA BONE MORPHOGENIC PROTEINS (BMP) MARKET, BY COUNTRY

6.3.1.1.2        EUROPE BONE MORPHOGENIC PROTEINS (BMP) MARKET, BY COUNTRY

6.3.1.1.3        ASIA-PACIFIC BONE MORPHOGENIC PROTEINS (BMP) MARKET, BY COUNTRY

6.3.1.1.4        REST OF WORLD BONE MORPHOGENIC PROTEINS (BMP) MARKET, BY COUNTRY

6.3.1.2        SYNTHETIC BONE GRAFTS MARKET, BY REGION

6.3.1.2.1        NORTH AMERICA SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY

6.3.1.2.2        EUROPE SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY

6.3.1.2.3        ASIA-PACIFIC SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY

6.3.1.2.4        REST OF WORLD SYNTHETIC BONE GRAFTS MARKET, BY COUNTRY

6.3.2             BONE GRAFT SUBSTITUTES MARKET, BY REGION

6.3.2.1        NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY

6.3.2.2        EUROPE BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY

6.3.2.3        ASIA-PACIFIC BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY

6.3.2.4        REST OF WORLD BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY

6.4.           CELL BASED MATRICES (CBM)

6.4.1             CELL BASED MATRICES (CBM) MARKET, BY REGION

6.4.1.1        NORTH AMERICA CELL BASED MATRICES (CBM) MARKET, BY COUNTRY

6.4.1.2        EUROPE CELL BASED MATRICES (CBM) MARKET, BY COUNTRY

6.4.1.3        ASIA-PACIFIC CELL BASED MATRICES (CBM) MARKET, BY COUNTRY

6.4.1.4        REST OF WORLD CELL BASED MATRICES (CBM) MARKET, BY COUNTRY

7. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

7.1.           OVERVIEW

7.2.           SPINAL FUSION

7.2.1             SPINAL FUSION MARKET, BY REGION

7.2.1.1        NORTH AMERICA SPINAL FUSION MARKET, BY COUNTRY

7.2.1.2        EUROPE SPINAL FUSION MARKET, BY COUNTRY

7.2.1.3        ASIA-PACIFIC SPINAL FUSION MARKET, BY COUNTRY

7.2.1.4        REST OF WORLD SPINAL FUSION MARKET, BY COUNTRY

7.3.           TRAUMA

7.3.1             TRAUMA MARKET, BY REGION

7.3.1.1        NORTH AMERICA TRAUMA MARKET, BY COUNTRY

7.3.1.2        EUROPE TRAUMA MARKET, BY COUNTRY

7.3.1.3        ASIA-PACIFIC TRAUMA MARKET, BY COUNTRY

7.3.1.4        REST OF WORLD TRAUMA MARKET, BY COUNTRY

7.4.           CRANIOMAXILLOFACIAL SURGERY

7.4.1             CRANIOMAXILLOFACIAL SURGERY MARKET, BY REGION

7.4.1.1        NORTH AMERICA CRANIOMAXILLOFACIAL SURGERY MARKET, BY COUNTRY

7.4.1.2        EUROPE CRANIOMAXILLOFACIAL SURGERY MARKET, BY COUNTRY

7.4.1.3        ASIA-PACIFIC CRANIOMAXILLOFACIAL SURGERY MARKET, BY COUNTRY

7.4.1.4        REST OF WORLD CRANIOMAXILLOFACIAL SURGERY MARKET, BY COUNTRY

7.5.           JOINT RECONSTRUCTION

7.5.1             JOINT RECONSTRUCTION MARKET, BY REGION

7.5.1.1        NORTH AMERICA JOINT RECONSTRUCTION MARKET, BY COUNTRY

7.5.1.2        EUROPE JOINT RECONSTRUCTION MARKET, BY COUNTRY

7.5.1.3        ASIA-PACIFIC JOINT RECONSTRUCTION MARKET, BY COUNTRY

7.5.1.4        REST OF WORLD JOINT RECONSTRUCTION MARKET, BY COUNTRY

7.6.           DENTAL BONE GRAFTING

7.6.1             DENTAL BONE GRAFTING MARKET, BY REGION

7.6.1.1        NORTH AMERICA DENTAL BONE GRAFTING MARKET, BY COUNTRY

7.6.1.2        EUROPE DENTAL BONE GRAFTING MARKET, BY COUNTRY

7.6.1.3        ASIA-PACIFIC DENTAL BONE GRAFTING MARKET, BY COUNTRY

7.6.1.4        REST OF WORLD DENTAL BONE GRAFTING MARKET, BY COUNTRY

8. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION

8.1.           OVERVIEW

8.2.           NORTH AMERICA

8.2.1             NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.2.1.1        NORTH AMERICA  ALLOGRAFT MARKET, BY PRODUCT

8.2.1.2        NORTH AMERICA  BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.2.2             NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.2.3             NORTH AMERICA BONE GRAFTS AND SUBSTITUTES, MARKET BY COUNTRY

8.2.3.1        U.S

8.2.3.1.1        U.S BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.2.3.1.1.1. U.S ALLOGRAFT MARKET, BY PRODUCT

8.2.3.1.1.2. U.S BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.2.3.1.2        U.S BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.2.3.2        CANADA

8.2.3.2.1        CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.2.3.2.1.1. CANADA ALLOGRAFT MARKET, BY PRODUCT

8.2.3.2.1.2. CANADA BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.2.3.2.2        CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.2.3.3        MEXICO

8.2.3.3.1        MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.2.3.3.1.1. MEXICO ALLOGRAFT MARKET, BY PRODUCT

8.2.3.3.1.2. MEXICO BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.2.3.3.2        MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.           EUROPE

8.3.1             EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.1.1        EUROPE  ALLOGRAFT MARKET, BY PRODUCT

8.3.1.2        EUROPE  BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.2             EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3             EUROPE BONE GRAFTS AND SUBSTITUTES, MARKET BY COUNTRY

8.3.3.1        UK

8.3.3.1.1        UK BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.1.1.1. UK ALLOGRAFT MARKET, BY PRODUCT

8.3.3.1.1.2. UK BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.1.2        UK BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3.2        GERMANY

8.3.3.2.1        GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.2.1.1. GERMANY ALLOGRAFT MARKET, BY PRODUCT

8.3.3.2.1.2. GERMANY BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.2.2        GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3.3        FRANCE

8.3.3.3.1        FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.3.1.1. FRANCE ALLOGRAFT MARKET, BY PRODUCT

8.3.3.3.1.2. FRANCE BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.3.2        FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3.4        ITALY

8.3.3.4.1        ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.4.1.1. ITALY ALLOGRAFT MARKET, BY PRODUCT

8.3.3.4.1.2. ITALY BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.4.2        ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3.5        SPAIN

8.3.3.5.1        SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.5.1.1. SPAIN ALLOGRAFT MARKET, BY PRODUCT

8.3.3.5.1.2. SPAIN BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.5.2        SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3.6        UK

8.3.3.6.1        UK BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.6.1.1. UK ALLOGRAFT MARKET, BY PRODUCT

8.3.3.6.1.2. UK BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.6.2        UK BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.3.3.7        REST OF EUROPE

8.3.3.7.1        REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.3.3.7.1.1. REST OF EUROPE ALLOGRAFT MARKET, BY PRODUCT

8.3.3.7.1.2. REST OF EUROPE BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.3.3.7.2        REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.4.           ASIA-PACIFIC

8.4.1             ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.4.1.1        ASIA-PACIFIC  ALLOGRAFT MARKET, BY PRODUCT

8.4.1.2        ASIA-PACIFIC  BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.4.2             ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.4.3             ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES, MARKET BY COUNTRY

8.4.3.1        CHINA

8.4.3.1.1        CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.4.3.1.1.1. CHINA ALLOGRAFT MARKET, BY PRODUCT

8.4.3.1.1.2. CHINA BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.4.3.1.2        CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.4.3.2        JAPAN

8.4.3.2.1        JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.4.3.2.1.1. JAPAN ALLOGRAFT MARKET, BY PRODUCT

8.4.3.2.1.2. JAPAN BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.4.3.2.2        JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.4.3.3        INDIA

8.4.3.3.1        INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.4.3.3.1.1. INDIA ALLOGRAFT MARKET, BY PRODUCT

8.4.3.3.1.2. INDIA BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.4.3.3.2        INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.4.3.4        SOUTH KOREA

8.4.3.4.1        SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.4.3.4.1.1. SOUTH KOREA ALLOGRAFT MARKET, BY PRODUCT

8.4.3.4.1.2. SOUTH KOREA BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.4.3.4.2        SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.4.3.5        REST OF ASIA-PACIFIC

8.4.3.5.1        REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.4.3.5.1.1. REST OF ASIA-PACIFIC ALLOGRAFT MARKET, BY PRODUCT

8.4.3.5.1.2. REST OF ASIA-PACIFIC BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.4.3.5.2        REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.5.           REST OF WORLD

8.5.1             REST OF WORLD BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.5.1.1        REST OF WORLD  ALLOGRAFT MARKET, BY PRODUCT

8.5.1.2        REST OF WORLD  BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.5.2             REST OF WORLD BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.5.3             REST OF WORLD BONE GRAFTS AND SUBSTITUTES, MARKET BY COUNTRY

8.5.3.1        BRAZIL

8.5.3.1.1        BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.5.3.1.1.1. BRAZIL ALLOGRAFT MARKET, BY PRODUCT

8.5.3.1.1.2. BRAZIL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.5.3.1.2        BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.5.3.2        ISRAEL

8.5.3.2.1        ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.5.3.2.1.1. ISRAEL ALLOGRAFT MARKET, BY PRODUCT

8.5.3.2.1.2. ISRAEL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.5.3.2.2        ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.5.3.3        SAUDI ARABIA

8.5.3.3.1        SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.5.3.3.1.1. SAUDI ARABIA ALLOGRAFT MARKET, BY PRODUCT

8.5.3.3.1.2. SAUDI ARABIA BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.5.3.3.2        SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

8.5.3.4        SOUTH AFRICA

8.5.3.4.1        SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY PRODUCT

8.5.3.4.1.1. SOUTH AFRICA ALLOGRAFT MARKET, BY PRODUCT

8.5.3.4.1.2. SOUTH AFRICA BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

8.5.3.4.2        SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION

9. COMPANY PROFILES

9.1.           ARTHREX, INC.

9.1.1             COMPANY OVERVIEW

9.1.2             COMPANY SNAPSHOT

9.1.3             OPERATING BUSINESS SEGMENTS

9.1.4             PRODUCT PORTFOLIO

9.1.5             BUSINESS PERFORMANCE

9.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.2.           BAXTER INTERNATIONAL INC.

9.2.1             COMPANY OVERVIEW

9.2.2             COMPANY SNAPSHOT

9.2.3             OPERATING BUSINESS SEGMENTS

9.2.4             PRODUCT PORTFOLIO

9.2.5             BUSINESS PERFORMANCE

9.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.3.           INTEGRA LIFESCIENCES HOLDINGS CORPORATION

9.3.1             COMPANY OVERVIEW

9.3.2             COMPANY SNAPSHOT

9.3.3             OPERATING BUSINESS SEGMENTS

9.3.4             PRODUCT PORTFOLIO

9.3.5             BUSINESS PERFORMANCE

9.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.4.           JOHNSON & JOHNSON (DEPUY SYNTHES)

9.4.1             COMPANY OVERVIEW

9.4.2             COMPANY SNAPSHOT

9.4.3             OPERATING BUSINESS SEGMENTS

9.4.4             PRODUCT PORTFOLIO

9.4.5             BUSINESS PERFORMANCE

9.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.5.           MEDTRONIC PLC.

9.5.1             COMPANY OVERVIEW

9.5.2             COMPANY SNAPSHOT

9.5.3             OPERATING BUSINESS SEGMENTS

9.5.4             PRODUCT PORTFOLIO

9.5.5             BUSINESS PERFORMANCE

9.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.6.           MUSCULOSKELETAL TRANSPLANT FOUNDATION

9.6.1             COMPANY OVERVIEW

9.6.2             COMPANY SNAPSHOT

9.6.3             OPERATING BUSINESS SEGMENTS

9.6.4             PRODUCT PORTFOLIO

9.6.5             BUSINESS PERFORMANCE

9.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.7.           NUVASIVE, INC.

9.7.1             COMPANY OVERVIEW

9.7.2             COMPANY SNAPSHOT

9.7.3             OPERATING BUSINESS SEGMENTS

9.7.4             PRODUCT PORTFOLIO

9.7.5             BUSINESS PERFORMANCE

9.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.8.           STRYKER CORPORATION

9.8.1             COMPANY OVERVIEW

9.8.2             COMPANY SNAPSHOT

9.8.3             OPERATING BUSINESS SEGMENTS

9.8.4             PRODUCT PORTFOLIO

9.8.5             BUSINESS PERFORMANCE

9.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.9.           WRIGHT MEDICAL GROUP N.V.

9.9.1             COMPANY OVERVIEW

9.9.2             COMPANY SNAPSHOT

9.9.3             OPERATING BUSINESS SEGMENTS

9.9.4             PRODUCT PORTFOLIO

9.9.5             BUSINESS PERFORMANCE

9.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.10.         ZIMMER BIOMET HOLDINGS, INC.

9.10.1           COMPANY OVERVIEW

9.10.2           COMPANY SNAPSHOT

9.10.3           OPERATING BUSINESS SEGMENTS

9.10.4           PRODUCT PORTFOLIO

9.10.5           BUSINESS PERFORMANCE

9.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 2. GLOBAL ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 3. DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 4. NORTH AMERICA DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 5. EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 6. ASIA-PACIFIC DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 7. REST OF WORLD DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 8. MACHINED ALLOGRAFTS MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 9. NORTH AMERICA MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 10. EUROPE MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 11. ASIA-PACIFIC MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 12. REST OF WORLD MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 13. ALLOGRAFT MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 14. NORTH AMERICA ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 15. EUROPE ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 16. ASIA-PACIFIC ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 17. REST OF WORLD ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 18. GLOBAL BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 19. BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 20. NORTH AMERICA BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 21. EUROPE BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 22. ASIA-PACIFIC BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 23. REST OF WORLD BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 24. SYNTHETIC BONE GRAFTS MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 25. NORTH AMERICA SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 26. EUROPE SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 27. ASIA-PACIFIC SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 28. REST OF WORLD SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 29. BONE GRAFT SUBSTITUTES MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 30. NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 31. EUROPE BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 32. ASIA-PACIFIC BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 33. REST OF WORLD BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 34. CELL BASED MATRICES (CBM) MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 35. NORTH AMERICA CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 36. EUROPE CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 37. ASIA-PACIFIC CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 38. REST OF WORLD CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 39. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 40. SPINAL FUSION MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 41. NORTH AMERICA SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 42. EUROPE SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 43. ASIA-PACIFIC SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 44. REST OF WORLD SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 45. TRAUMA MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 46. NORTH AMERICA TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 47. EUROPE TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 48. ASIA-PACIFIC TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 49. REST OF WORLD TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 50. CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 51. NORTH AMERICA CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 52. EUROPE CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 53. ASIA-PACIFIC CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 54. REST OF WORLD CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 55. JOINT RECONSTRUCTION MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 56. NORTH AMERICA JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 57. EUROPE JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 58. ASIA-PACIFIC JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 59. REST OF WORLD JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 60. DENTAL BONE GRAFTING MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 61. NORTH AMERICA DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 62. EUROPE DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 63. ASIA-PACIFIC DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 64. REST OF WORLD DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

TABLE 65. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY REGION, 2022-2030, MILLION USD

TABLE 66. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 67. NORTH AMERICA  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 68. NORTH AMERICA  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 69. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 70. U.S BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 71. U.S ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 72. U.S BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 73. U.S BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 74. CANADA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 75. CANADA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 76. CANADA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 77. CANADA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 78. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 79. MEXICO ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 80. MEXICO BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 81. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 82. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 83. EUROPE  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 84. EUROPE  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 85. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 86. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 87. UK ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 88. UK BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 89. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 90. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 91. GERMANY ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 92. GERMANY BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 93. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 94. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 95. FRANCE ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 96. FRANCE BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 97. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 98. ITALY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 99. ITALY ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 100. ITALY BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 101. ITALY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 102. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 103. SPAIN ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 104. SPAIN BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 105. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 106. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 107. UK ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 108. UK BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 109. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 110. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 111. REST OF EUROPE ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 112. REST OF EUROPE BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 113. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 114. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 115. ASIA-PACIFIC  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 116. ASIA-PACIFIC  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 117. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 118. CHINA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 119. CHINA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 120. CHINA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 121. CHINA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 122. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 123. JAPAN ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 124. JAPAN BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 125. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 126. INDIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 127. INDIA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 128. INDIA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 129. INDIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 130. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 131. SOUTH KOREA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 132. SOUTH KOREA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 133. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 134. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 135. REST OF ASIA-PACIFIC ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 136. REST OF ASIA-PACIFIC BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 137. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 138. REST OF WORLD BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 139. REST OF WORLD  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 140. REST OF WORLD  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 141. REST OF WORLD BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 142. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 143. BRAZIL ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 144. BRAZIL BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 145. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 146. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 147. ISRAEL ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 148. ISRAEL BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 149. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 150. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 151. SAUDI ARABIA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 152. SAUDI ARABIA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 153. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 154. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 155. SOUTH AFRICA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 156. SOUTH AFRICA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

TABLE 157. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

TABLE 158. ARTHREX, INC.: COMPANY SNAPSHOT

TABLE 159. ARTHREX, INC.: OPERATING SEGMENTS

TABLE 160. ARTHREX, INC.: PRODUCT PORTFOLIO

TABLE 161. ARTHREX, INC.: KEY STRATERGY

TABLE 162. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 163. BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS

TABLE 164. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 165. BAXTER INTERNATIONAL INC.: KEY STRATERGY

TABLE 166. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT

TABLE 167. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS

TABLE 168. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO

TABLE 169. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATERGY

TABLE 170. JOHNSON & JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT

TABLE 171. JOHNSON & JOHNSON (DEPUY SYNTHES): OPERATING SEGMENTS

TABLE 172. JOHNSON & JOHNSON (DEPUY SYNTHES): PRODUCT PORTFOLIO

TABLE 173. JOHNSON & JOHNSON (DEPUY SYNTHES): KEY STRATERGY

TABLE 174. MEDTRONIC PLC.: COMPANY SNAPSHOT

TABLE 175. MEDTRONIC PLC.: OPERATING SEGMENTS

TABLE 176. MEDTRONIC PLC.: PRODUCT PORTFOLIO

TABLE 177. MEDTRONIC PLC.: KEY STRATERGY

TABLE 178. MUSCULOSKELETAL TRANSPLANT FOUNDATION: COMPANY SNAPSHOT

TABLE 179. MUSCULOSKELETAL TRANSPLANT FOUNDATION: OPERATING SEGMENTS

TABLE 180. MUSCULOSKELETAL TRANSPLANT FOUNDATION: PRODUCT PORTFOLIO

TABLE 181. MUSCULOSKELETAL TRANSPLANT FOUNDATION: KEY STRATERGY

TABLE 182. NUVASIVE, INC.: COMPANY SNAPSHOT

TABLE 183. NUVASIVE, INC.: OPERATING SEGMENTS

TABLE 184. NUVASIVE, INC.: PRODUCT PORTFOLIO

TABLE 185. NUVASIVE, INC.: KEY STRATERGY

TABLE 186. STRYKER CORPORATION: COMPANY SNAPSHOT

TABLE 187. STRYKER CORPORATION: OPERATING SEGMENTS

TABLE 188. STRYKER CORPORATION: PRODUCT PORTFOLIO

TABLE 189. STRYKER CORPORATION: KEY STRATERGY

TABLE 190. WRIGHT MEDICAL GROUP N.V.: COMPANY SNAPSHOT

TABLE 191. WRIGHT MEDICAL GROUP N.V.: OPERATING SEGMENTS

TABLE 192. WRIGHT MEDICAL GROUP N.V.: PRODUCT PORTFOLIO

TABLE 193. WRIGHT MEDICAL GROUP N.V.: KEY STRATERGY

TABLE 194. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT

TABLE 195. ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS

TABLE 196. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO

TABLE 197. ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2019

FIGURE 2. MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2019

FIGURE 3. MARKET SHARE ANALYSIS: DEMINERALIZED BONE MATRIX, 2019

FIGURE 4. MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2019

FIGURE 5. MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2019

FIGURE 6. MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2019

FIGURE 7. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 8. GLOBAL ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 9. DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 10. NORTH AMERICA DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 11. EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 12. ASIA-PACIFIC DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 13. REST OF WORLD DEMINERALIZED BONE MATRIX (DBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 14. MACHINED ALLOGRAFTS MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 15. NORTH AMERICA MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 16. EUROPE MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 17. ASIA-PACIFIC MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 18. REST OF WORLD MACHINED ALLOGRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 19. ALLOGRAFT MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 20. NORTH AMERICA ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 21. EUROPE ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 22. ASIA-PACIFIC ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 23. REST OF WORLD ALLOGRAFT MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 24. GLOBAL BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 25. BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 26. NORTH AMERICA BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 27. EUROPE BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 28. ASIA-PACIFIC BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 29. REST OF WORLD BONE MORPHOGENIC PROTEINS (BMP) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 30. SYNTHETIC BONE GRAFTS MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 31. NORTH AMERICA SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 32. EUROPE SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 33. ASIA-PACIFIC SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 34. REST OF WORLD SYNTHETIC BONE GRAFTS MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 35. BONE GRAFT SUBSTITUTES MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 36. NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 37. EUROPE BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 38. ASIA-PACIFIC BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 39. REST OF WORLD BONE GRAFT SUBSTITUTES MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 40. CELL BASED MATRICES (CBM) MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 41. NORTH AMERICA CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 42. EUROPE CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 43. ASIA-PACIFIC CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 44. REST OF WORLD CELL BASED MATRICES (CBM) MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 45. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 46. SPINAL FUSION MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 47. NORTH AMERICA SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 48. EUROPE SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 49. ASIA-PACIFIC SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 50. REST OF WORLD SPINAL FUSION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 51. TRAUMA MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 52. NORTH AMERICA TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 53. EUROPE TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 54. ASIA-PACIFIC TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 55. REST OF WORLD TRAUMA MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 56. CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 57. NORTH AMERICA CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 58. EUROPE CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 59. ASIA-PACIFIC CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 60. REST OF WORLD CRANIOMAXILLOFACIAL SURGERY MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 61. JOINT RECONSTRUCTION MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 62. NORTH AMERICA JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 63. EUROPE JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 64. ASIA-PACIFIC JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 65. REST OF WORLD JOINT RECONSTRUCTION MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 66. DENTAL BONE GRAFTING MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 67. NORTH AMERICA DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 68. EUROPE DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 69. ASIA-PACIFIC DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 70. REST OF WORLD DENTAL BONE GRAFTING MARKET VALUE, BY COUNTRY, 2022-2030, MILLION USD

FIGURE 71. GLOBAL  BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY REGION, 2022-2030, MILLION USD

FIGURE 72. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 73. NORTH AMERICA  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 74. NORTH AMERICA  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 75. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 76. U.S BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 77. U.S ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 78. U.S BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 79. U.S BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 80. CANADA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 81. CANADA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 82. CANADA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 83. CANADA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 84. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 85. MEXICO ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 86. MEXICO BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 87. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 88. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 89. EUROPE  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 90. EUROPE  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 91. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 92. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 93. UK ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 94. UK BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 95. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 96. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 97. GERMANY ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 98. GERMANY BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 99. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 100. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 101. FRANCE ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 102. FRANCE BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 103. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 104. ITALY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 105. ITALY ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 106. ITALY BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 107. ITALY BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 108. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 109. SPAIN ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 110. SPAIN BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 111. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 112. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 113. UK ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 114. UK BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 115. UK BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 116. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 117. REST OF EUROPE ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 118. REST OF EUROPE BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 119. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 120. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 121. ASIA-PACIFIC  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 122. ASIA-PACIFIC  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 123. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 124. CHINA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 125. CHINA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 126. CHINA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 127. CHINA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 128. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 129. JAPAN ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 130. JAPAN BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 131. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 132. INDIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 133. INDIA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 134. INDIA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 135. INDIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 136. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 137. SOUTH KOREA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 138. SOUTH KOREA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 139. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 140. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 141. REST OF ASIA-PACIFIC ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 142. REST OF ASIA-PACIFIC BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 143. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 144. REST OF WORLD BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 145. REST OF WORLD  ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 146. REST OF WORLD  BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 147. REST OF WORLD BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 148. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 149. BRAZIL ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 150. BRAZIL BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 151. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 152. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 153. ISRAEL ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 154. ISRAEL BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 155. ISRAEL BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 156. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 157. SAUDI ARABIA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 158. SAUDI ARABIA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 159. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 160. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 161. SOUTH AFRICA ALLOGRAFT MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 162. SOUTH AFRICA BONE GRAFT SUBSTITUTES MARKET VALUE, BY PRODUCT, 2022-2030, MILLION USD

FIGURE 163. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET VALUE, BY APPLICATION, 2022-2030, MILLION USD

FIGURE 164. ARTHREX, INC.: NET SALES,2017-2019

FIGURE 165. BAXTER INTERNATIONAL INC.: NET SALES,2017-2019

FIGURE 166. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES,2017-2019

FIGURE 167. JOHNSON & JOHNSON (DEPUY SYNTHES): NET SALES,2017-2019

FIGURE 168. MEDTRONIC PLC.: NET SALES,2017-2019

FIGURE 169. MUSCULOSKELETAL TRANSPLANT FOUNDATION: NET SALES,2017-2019

FIGURE 170. NUVASIVE, INC.: NET SALES,2017-2019

FIGURE 171. STRYKER CORPORATION: NET SALES,2017-2019

FIGURE 172. WRIGHT MEDICAL GROUP N.V.: NET SALES,2017-2019

FIGURE 173. ZIMMER BIOMET HOLDINGS, INC.: NET SALES,2017-2019

KEY PLAYERS

  • Baxter International Inc.

  • Integra LifeSciences Holdings Corporation

  • Arthrex, Inc.

  • Johnson & Johnson

  • Wright Medical Group N.V.

  • Medtronic Plc.

  • Zimmer Biomet Holdings, Inc.

  • Stryker Corporation

  • Musculoskeletal Transplant Foundation

  • NuVasive, Inc.


Frequently Asked Questions
What will be the worth of global bone grafts and substitutes market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the bone grafts and substitutes market business is expected to hit at $4.85 billion (USD) by 2030.

Which region is expected to hold the highest market share in the bone grafts and substitutes market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the bone grafts and substitutes industry?

Johnson & Johnson, Arthrex, Inc., Baxter International Inc., Zimmer Biomet Holdings, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Stryker Corporation, Musculoskeletal Transplant Foundation, NuVasive, Inc., Medtronic Plc., Inc., and others.

What are the market segmentations and scope of the study?

The bone grafts and substitutes market share analysis is based on type, application, end user, and geography.

How big is the bone grafts and substitutes market?

Currently (in 2019), the market value stands at USD 2.96 billion and it is anticipated to reach USD 4.85 billion by 2030.